Working to protect human health from infectious diseases through Fusogenix technology and next-generation vaccines/therapeutics. We will do whatever it takes.
Aegis Life, Inc. is a next-generation biotechnology company revolutionizing the way we prevent and treat infectious diseases. The company was founded in early 2020 to combat COVID-19, but our roots go back to more than a decade of gene delivery research and development. With our breakthrough technology “Fusogenix”, we can rapidly develop vaccines and therapeutics to fight COVID-19 and other emerging contagions. We are actively building the industry’s leading genetic medicine platform that can accelerate the discovery, clinical development and manufacture of vaccines and therapeutics for infectious diseases.
Be the first to know and let us send you an email when Aegis Life, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
